Analysts at J.P. Morgan on Friday upgraded theater operator Cinemark (NYSE:CNK) to "overweight" from "neutral," while sticking to its investment rating of "neutral" on IMAX (NYSE:IMAX). They said that ...

"In 1976 Argentina, on the eve of a political revolution, a teacher and his students at an exclusive boys school are enlightened by an unusual guest." ...

JP Morgan upgraded Cinemark Holdings (NYSE:CNK) to “Overweight” from “Neutral” on growing confidence in the 2026-2027 film pipeline and reduced box office expectations for 2025 that now better align ...

AMC Theatres (NYSE:AMC) and Cinemark (NYSE:CNK) saw strong foot traffic at their theaters during the first weekend of April, ...

Experience the ultimate movie-going experience at Cinemark theaters. Enjoy the latest blockbusters, classic films, and live events on state-of-the-art screens and sound systems. Explore Cinemark ...

In a report released today, Eric Handler from Roth MKM maintained a Buy rating on IMAX (IMAX – Research Report), with a price target of $32.00.

High-end movie-theater operator IMAX Corp. is well-positioned to shine in a tough macroeconomic environment, according to analyst firm Benchmark. “Historical data indicates that during six of ...

Starting Wednesday when Godzilla vs. Kong opens, Imax tickets for select seats at the Chinese Theatre will be $5 for two weeks. In conjunction with promo partner, The HollyGold Foundation ...